Strikingly, a higher level of TEAD4-S was significantly associated with the improved overall survival in patients with lung and colon cancers (Fig. 5f), and to a lesser extent, in patients with liver and breast cancers (Supplementary Fig. 4b, positive but non-significant association). Here, TEAD4 is linked to breast cancer.